The rise in the number of patents expiry, growing number of biological drugs in development, robust drug candidates in the pipeline, and increasing generic competition for achieving cost efficiency augmenting significant demand for the active pharmaceutical ingredient. In addition, key players are also securing long-term supply agreements to manufacture active pharmaceutical ingredients and new drug products. For which, these players are partnering with generic drug companies to grow the company’s extensive portfolio of generic API’s. For instance, In 2016 Pfizer aggressively acquired and partnered with Astra Zeneca, Watson Health, Medivation, Bamboo Therapeutics, Anacor, and Adaptive Biotechnologies in order to expand its product portfolio. Such facts would, in turn, establish a healthy platform for industry growth.

Request exclusive PDF sample copy of the report:
www.analystviewmarketinsights.com/request_sample/av120/

Key Takeaways:

-In terms of manufacturer, the market is divided into captive and merchant. Captive segment captured more than 55% share of the global active pharmaceutical ingredient market.
-Synthesis segment is categorized as synthetic and biologic. The synthetic segment accounted for a major chunk of the industry revenue throughout the study period.
-Drug type category is divided into generic and branded. The generic segment is growing with the highest growth rate over the study period.
-In terms of therapeutic area, the market is divided into Cardiovascular, Metabolic, CNS, Oncology, Musculoskeletal, NSAIDS, and others. Of these, the cardiovascular segment recorded USD 40.23 billion in 2016 and is anticipated to dominate the global market. Increasing incidences of cardiovascular disease have helped this segment to capture significant revenue share.
-Companies namely Boehringer Ingelheim GmbH, Teva Pharmaceuticals. Pfizer, Inc, Novartis AG, Cambrex Corporation, Lonza Group, and Mylan N.V. are actively operating in this industry.
-Teva Pharmaceuticals accounted for the highest revenue share of the global API market with more than 300 API products under the offering
-Teva is exploring both organic as well as corporate development initiatives to achieve a leadership position in this industry, including the acquisition of Rimsa, a Mexico based leading pharmaceutical company in March 2016.

Browse full research highlight with in-depth ToC on “Active Pharmaceutical Ingredient Market, By Manufacturer, By Synthesis, Drug Type, By Therapeutic Area, and Geography – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” at

www.analystviewmarketinsights.com/report-highlight-active-pharmaceutical-ingredient-market-120/

The scope of this report covers the market by its major segments, as follows:

MARKET, BY MANUFACTURER
-Captive
-Merchant

MARKET, BY SYNTHESIS
-Synthetic
-Biological

MARKET, BY DRUG TYPE
-Generic
-Branded

MARKET, BY THERAPEUTIC AREA
-Cardiovascular
-Metabolic
-CNS
-Oncology
-Musculoskeletal
-NSAIDS
-Others

MARKET, BY REGION
-North America
-U.S.
-Canada
-Europe
-Germany
-France
-Rest of Europe
-Asia Pacific
-India
-China
-Rest of APAC
-Rest of the World
-Middle East and Africa
-Latin America

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles):
Boehringer Ingelheim GmbH
Teva Pharmaceuticals
Pfizer, Inc.
Novartis AG
Cambrex Corporation
Lonza Group
Mylan N.V.

Key Question Answered:
What are the key market trends, drivers, barriers, opportunities and recommendations?
What will the market size be from 2014 to 2025 and expected growth rate?
What is the revenue share of active pharmaceutical ingredient market, by types, by therapy, and by different geographies?
Who are the largest revenue contributor as well as fastest growing category for respective industry segments?
Who are the key vendors in Global Active Pharmaceutical Ingredient Market space?
What are the strategies adopted by key vendors to expand their market presence?
What is the revenue share of key players operating in this market (2017)?
Please note that preparing of customized report catering to a particular region or country is also possible within quicker timeframe as we follow bottom-up research methodology

Value Proposition:
•We are committed to provide valuable insights to our clients in order to help them take strategic decisions and in turn influencing revenue growth. The proposed study answers several important questions for stakeholders, primarily which industry segments to focus on in the next three to five years for prioritizing investments
•The proposed report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
•A thorough analysis of relevant statistical data to estimate the market paradigms
•Exceptional understanding of the region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
•Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Find out more by getting in touch: https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: [email protected]
Web: www.analystviewmarketinsights.com